Palantir's Q4 results were astounding, "eviscerating" (their words in the press release) the consensus. I looked that up—it ...

Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MNDY usually suggests something ...

Pivotal Research raised the firm’s price target on Spotify (SPOT) to $725 from $615 and keeps a Buy rating on the shares. Spotify reported an ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, ...

BofA raised the firm’s price target on Argenx (ARGX) to $774 from $770 and keeps a Buy rating on the shares. The company pre-announced Q4 ...

Innate Pharma (NASDAQ:IPHA – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based ...

We recently published a list of 12 Most Buzzing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other ...

Read here for a discussion Target's Q3 earnings miss, strong Q4 performance, attractive valuation, and positive outlook from ...

Target faces macro and cyclical headwinds, with consumer discretionary spending and macro sentiment likely driving the stock ...

Target Corp.’s stock rose early Thursday before surrendering those gains, after the retailer raised guidance for a key metric in an update on its holiday sales, after achieving records for both ...

At first blush, very high “consensus” analyst target prices—that is ... In a new paper, Steffen, Zhang, and Palley say that when dispersion is low—meaning analysts’ stock price predictions are more ...

Two Sharp with ET: RIL Q3 beats street, stock surges; Sensex, Nifty Slide on IT & Banking ... now have the ingredients to re-rate back to mid-cycle multiples with share target prices going up to Rs ...